NFGH
KYNB

Nan Fung Group Holdings’s Kyntra Bio KYNB Stock Holding History

Nan Fung Group Holdings’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,484
Closed -$55.4K – 43
2024
Q2 		$55.4K Hold
2,484
– – 0.06% 44
2024
Q1 		$146K Hold
2,484
– – 0.14% 44
2023
Q4 		$55K Hold
2,484
– – 0.03% 38
2023
Q3 		$53.6K Hold
2,484
– – 0.04% 37
2023
Q2 		$168K Buy
2,484
+1,120
+82% +$463K 0.11% 38
2023
Q1 		$636K Hold
1,364
– – 0.43% 27
2022
Q4 		$546K Buy
1,364
+774
+131% +$296K 0.38% 25
2022
Q3 		$192K Hold
590
– – 0.12% 33
2022
Q2 		$156K Hold
590
– – 0.11% 35
2022
Q1 		$177K Buy
+590
New +$206K 0.08% 38

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
GC
GFG Capital Miami, Florida $363M AUM 45.53% 1-Year Est. Return

Nan Fung Group Holdings's KYNB Position: Q3 2024 in Review

Nan Fung Group Holdings sold out of Kyntra Bio (KYNB) in Q3 2024, closing a stake of 2,484 shares — an estimated $55.4K sold.

Nan Fung Group Holdings first reported a position in KYNB in Q1 2022 and held it in 10 quarters. The position peaked at $636K in Q1 2023. 70 funds tracked by Wall St. Rank hold KYNB as of Q3 2024.

  • Nan Fung Group Holdings reported no remaining Kyntra Bio position as of Q3 2024 after selling out during the quarter.
  • Nan Fung Group Holdings sold 2,484 Kyntra Bio shares in Q3 2024, an estimated $55.4K.
  • Nan Fung Group Holdings first reported a position in Kyntra Bio in Q1 2022 and held it in 10 quarters.
  • Nan Fung Group Holdings's Kyntra Bio position peaked at $636K in Q1 2023.
  • 70 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2024.

Based on Nan Fung Group Holdings's 13F filing for Q3 2024, filed 13 Nov 2024.